Evidence map›Paper›PMID 41837120›Full record

ArticleFrontiers in endocrinology2026

Case Report: Morphologically striking eruptive xanthomas with lobulated papules: a sentinel sign of severe metabolic dysregulation.

Tiantian Lu, Fuyuan Zhuge, Wei Cai, Xiaofang Zhang, Dajun Lou, Dihua Huang

Abstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tiantian Lu *Department of Endocrinology, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Fuyuan Zhuge *Department of Endocrinology, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Wei CaiDepartment of Dermatology, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Xiaofang ZhangDepartment of Endocrinology, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Dajun LouDepartment of Endocrinology, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Dihua HuangDepartment of Endocrinology, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eruptive xanthoma (EX) is a rare but clinically important dermatologic manifestation of severe hypertriglyceridemia and often serves as a cutaneous indicator of profound disturbances in glucose metabolism. Here, we describe a 27-year-old man who presented with numerous yellowish papules that clustered into lobulated, cauliflower-like plaques on the trunk and limbs, serving as the first clinical indication of underlying metabolic dysregulation. Laboratory investigations revealed extreme hypertriglyceridemia (60.45 mmol/L) and newly diagnosed diabetes mellitus (HbA1c 14.1%). Skin biopsy demonstrated foamy histiocytes and Touton giant cells in the dermis. The patient received combination therapy with fenofibrate (200 mg/day), intensive insulin therapy, and a low-fat diabetic diet, leading to rapid normalization of triglyceride levels from 60.45 mmol/L to 2.47 mmol/L by Day 32. The cutaneous lesions flattened and progressively regressed in parallel with metabolic improvement, leaving only faint post-inflammatory hyperpigmentation at the final evaluation. This case emphasizes that uncommon lobulated morphology may serve as an early visual clue of eruptive xanthomas, reinforcing the diagnostic value of cutaneous signs as metabolic sentinels and highlighting that early dual-target treatment can prevent life-threatening complications.

Indexed as

HypertriglyceridemiaXanthomatosisAdultFenofibrateHumansMaleFenofibratecauliflower-like papuleseruptive xanthomafenofibrateinsulin therapymetabolic syndromenew-onset diabetessevere hypertriglyceridemia

Identifiers

PMID41837120
PMCPMC12982105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.